|
Jan 18, 2017
MilliporeSigma has introduced CAN MultiFlow™ screening services to more accurately predict genotoxic and mode of action* properties of substances, ingredients and drug compounds.
|
20170118 |
|
|
Jan 17, 2017
MilliporeSigma today announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media.
|
20170117 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Dec 05, 2016
MilliporeSigma today announced that it will provide its Provantage® End-to-End services to Acticor Biotech SAS for accelerated development and manufacturing of Acticor’s antibody fragment used for the primary treatment of ischemic stroke.
|
20161205 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Dec 02, 2016
MilliporeSigma today introduced Parteck® MXP, a polyvinyl alcohol-based excipient that enhances solubility of a wide range of active pharmaceutical ingredients (APIs) with poor bioavailability.
|
20161202 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Oct 06, 2016
MilliporeSigma today announced the opening of an M Lab™ Collaboration Center in the Songdo district of Incheon, Korea, one of the fastest growing biotech hubs in Asia.
|
20161006 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Oct 05, 2016
MilliporeSigma today announced that CEO Udit Batra was named “CEO of the Year” for 2016 by CPhI Pharma for his commitment to furthering life science innovation globally.
|
20161005 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Sep 26, 2016
MilliporeSigma today launched the Viresolve® Pro Shield H for removal of parvoviruses from therapeutic protein feed streams.
|
20160926 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Sep 08, 2016
MilliporeSigma today launched a first-of-its-kind gene editing technology to modify CHO cell lines to be resistant to minute virus of mice (MVM), a common contamination threat that remains despite the shift to chemically-defined, animal component-free manufacturing processes.
|
20160908 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Aug 01, 2016
MilliporeSigma will provide its Provantage® End-to-End development and manufacturing services to Y-mAbs Therapeutics, Inc. in support of Y-mAbs’ monoclonal antibody in late stage clinical development.
|
20160801 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Jul 18, 2016
MilliporeSigma today is relaunching its global network of customer collaboration centers, providing customers a shared, exploratory environment with scientists and engineers working to solve their toughest biomanufacturing challenges and helping accelerate development of new therapies.
|
20160718 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Jul 12, 2016
MilliporeSigma has entered into an agreement with PCAS S.A. (Longjumeau, France) to expand MilliporeSigma’s excipients portfolio.
|
20160712 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Jun 28, 2016
MilliporeSigma today has expanded its industry-leading Emprove® risk assessment program to include a selection of products for filtration and single-use processing.
|
20160628 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Jun 28, 2016
MilliporeSigma has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.
|
20160628 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Jun 07, 2016
MilliporeSigma today announced survey results of 250 global biopharmaceutical executives on how their companies will manage new risks associated with the changing biopharma landscape.
|
20160607 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
May 02, 2016
MilliporeSigma today announced the expansion of its state-of-the art single use current good manufacturing process (cGMP) facility with the addition of the Mobius® 2000L single-use bioreactor.
|
20160502 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
May 04, 2016
MilliporeSigma today announced an expansion of its Carlsbad, California facility to meet growing demand for viral and gene therapy products.
|
20160504 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Apr 27, 2016
MilliporeSigma is launching three Mobius® products that deliver improved efficiency and ease-of-use for biopharmaceutical manufacturing workflows.
|
20160427 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Apr 26, 2016
MilliporeSigma today announced the launch of its first-in-class Lynx® CDR connectors to improve fluid management in the biopharma industry.
|
20160426 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Oct 26, 2015
MilliporeSigma today introduced Parteck® SRP 80, a new functional excipient for oral sustained-release formulations.
|
20151026 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Oct 22, 2015
MilliporeSigma today announced the Company has entered into a strategic alliance with Turgut Ilaç, a leading biosimilars company based in Turkey and will provide their Provantage® End-to-End services for development and manufacturing of biologics.
|
20151022 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Oct 21, 2015
MilliporeSigma today introduced Millipore Express® PHF (process protection, high-flux) hydrophilic filters for fast, efficient and economical buffer filtration.
|
20151021 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Sep 28, 2015
MilliporeSigma today announced that it has published an original white paper, recognizing the impact the emerging biotech community has on the future of healthcare.
|
20150928 |
,Small Molecule Pharmaceuticals,Reagents Chemicals and Labware,Life Science Research,Industrial Biomonitoring,IVD/OEM Materials and Reagents,Biopharmaceutical Manufacturing,Analytics and Sample Preparation |
|
Sep 14, 2015
MilliporeSigma today introduced enhancements to its industry-leading Emprove® portfolio of pharmaceutical raw materials.
|
20150914 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Jul 27, 2015
MilliporeSigma today announced a collaboration with celares GmbH to provide pegylation services to customers developing protein-based therapeutics and biosimilars.
|
20150727 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Jun 15, 2015
MilliporeSigma today introduced the Mobius® 2000 liter single-use bioreactor. The 2000 liter bioreactor joins the Mobius® stirred tank bioreactor portfolio (from 3 to 2000 liters) that provides the ultimate in flexibility, scalability, and convenience.
|
20150615 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Jun 15, 2015
MilliporeSigma today announced expansion of its Provantage® Biodevelopment Services to include a Clone Generation Service.
|
20150615 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Jun 02, 2015
MilliporeSigma today introduced a new technology that compacts dry powder cell culture media into granules, accelerating solubility and improving flowability and handling.
|
20150602 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Jun 01, 2015
MilliporeSigma today announced the launch of its Cellvento™ CHO platform of cell culture media and companion feed formulations for batch, fed-batch and perfusion applications.
|
20150601 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
May 21, 2015
MilliporeSigma today introduced single-pass tangential flow filtration (TFF) with Pellicon® cassettes, an enhanced application of MilliporeSigma’s existing TFF technology that allows concentration of process streams without the recirculation required in traditional TFF.
|
20150521 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Feb 02, 2015
MilliporeSigma today announced an agreement for providing upstream process development services for Precision Biologics, Inc., a Texas-based clinical-stage biotechnology company, to advance a preclinical monoclonal antibody.
|
20150202 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Oct 21, 2014
MilliporeSigma has expanded its single-use film offerings with the introduction of PureFlex™ Plus film, a robust, durable film used in the construction of Mobius® single-use process containers for biopharmaceutical manufacturing.
|
20141021 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Sep 15, 2014
MilliporeSigma announced it has received two R&D Magazine 100 Awards for innovative products released to market in 2013.
|
20140915 |
Small Molecule Pharmaceuticals,Life Science Research,Biopharmaceutical Manufacturing |
|
Aug 20, 2014
MilliporeSigma announced today that MilliporeSigma and Samsung BioLogics signed an MOU (Memorandum of Understanding) for a strategic alliance on the biopharmaceutical business.
|
20140820 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
May 05, 2014
EMD Millipore today announces the expansion of its upstream services into North America as part of its Provantage® Biodevelopment and Clinical Supply offering.
|
20140505 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Feb 04, 2014
The DRYPOUR™ packaging system minimizes caking of hygroscopic salts used in pharmaceutical manufacturing during transport and storage.
|
20140204 |
Biopharmaceutical Manufacturing,Small Molecule Pharmaceuticals |
|
Jan 29, 2014
The portfolio includes EMPROVE® api for active pharmaceutical ingredients, EMPROVE® exp for excipients and EMPROVE® bio for biopharmaceutical materials.
|
20140129 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Jun 04, 2012
This new application facilitates large-scale production at up to one-third the cost per dose compared to cells grown in flat culture stacks.
|
20120604 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Aug 07, 2012
CellPrime™ Insulin stimulates the proliferation of cells and aids in carbohydrate metabolism, helping to ensure the long-term viability of various cell lines.
|
20120807 |
Biopharmaceutical Manufacturing |
|
May 02, 2013
EMD Millipore announced the settlement of patent infringement disputes between EMD Millipore and W.L. Gore & Associates, Inc. in the U.S. District Court for the District of Massachusetts.
|
20130502 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Nov 15, 2012
Built on EMD Millipore’s proven Eshmuno resin technology, the new media offers high aggregate removal efficiency and high dynamic binding capacity, supporting highly productive downstream bioprocessing.
|
20121115 |
Biopharmaceutical Manufacturing |
|
Jun 25, 2012
Donovan joined Millipore Corporation in 1988 and has held numerous sales leadership roles including Senior Director, North American Field Operations, and Director of Sales.
|
20120625 |
Biopharmaceutical Manufacturing |
|
Sep 17, 2013
Novel Clarisolve Depth Filters Deliver Unmatched Speed and Efficiency for Single-Stage Clarification of Pretreated Feed Streams
|
20130917 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Feb 27, 2012
EMD Millipore and Charles River will collaborate to integrate the TrueSpike™ technology into viral clearance services provided by Charles River.
|
20120227 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Mar 12, 2012
This joint project will focus on the development of a proprietary monitoring and control methodology, enabling robust growth of adherent human pluripotent stem cells.
|
20120312 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Sep 05, 2012
The new media formulation was designed for the long-term growth of Chinese Hamster Ovary (CHO) cells to express antibodies or protein products.
|
20120905 |
Biopharmaceutical Manufacturing |
|
Jun 24, 2013
Cellvento™ CHO-200 medium and its corresponding feeds do not contain hydrolysates or components of unknown composition, resulting in very good lot-to-lot consistency.
|
20130624 |
Biopharmaceutical Manufacturing |
|
Mar 01, 2012
The increased efficiency offered by CellPrime recombinant human lysozyme, combined with high activity levels, results in a reduction of overall production costs.
|
20120301 |
Biopharmaceutical Manufacturing |
|
May 01, 2013
He will assume leadership effective May 14, 2012 and be based at the company’s U.S. headquarters in Massachusetts.
|
20130501 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Sep 19, 2012
This project will focus on the development required to ensure removal of microcarriers and any particulates from stem cell products grown in the Mobius® CellReady disposable bioreactor.
|
20120919 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Oct 09, 2012
This includes products for all types of dosage forms that address solubility, PK/PD modification, which must be taken into account for optimized bioavailability in the final drug.
|
20121009 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Nov 01, 2012
The two companies are jointly developing a methodology utilizing Sistemic’s microRNA marker detection capability to enable consistent growth of stem cells.
|
20121101 |
Small Molecule Pharmaceuticals,Life Science Research,Biopharmaceutical Manufacturing |
|
Aug 14, 2012
PureGenome library preparation is a simple, two-step process followed by amplification using EMD Millipore’s ultra-high fidelity KOD Hot Start DNA Polymerase Mastermix.
|
20120814 |
Reagents Chemicals and Labware,Life Science Research |
|
Jun 20, 2012
Provantage Solutions provide greater control and increased flexibility for both small and large molecule development and manufacturing processes.
|
20120620 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
May 21, 2013
The companies will work together to produce protocols and methods for efficient expansion, harvest and use of HepaRG® cells in support of the BALANCE project.
|
20130521 |
Biopharmaceutical Manufacturing |
|
Apr 10, 2012
Presentations and discussions will explore the recent launch of the new excipients certification program EXCiPACT™.
|
20120410 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Oct 22, 2013
Featuring a unique pore structure, Parteck SLC for drug delivery enables loading of oral dosage forms with amorphously distributed API to the highest levels.
|
20131022 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Aug 08, 2012
This novel design protects product integrity and prevents product loss during sample collection, transport and especially during long term storage where stress release can induce leakage.
|
20120808 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Jul 12, 2013
The center will accelerate growth of the company’s portfolio of innovative technologies and products that overcome bioavailability and formulation challenges
|
20130712 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Sep 20, 2012
The site will serve users of EMD Millipore’s Provantage™ Biodevelopment and Clinical Supply Solutions option that incorporates the latest technologies for upstream and downstream processes.
|
20120920 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Jan 07, 2013
Unlike traditional single-use processing systems, this modular system is quick and easy to set up, providing the ability to switch from TFF to Chromatography.
|
20130107 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Aug 06, 2012
The Mobius FlexReady Solution with Smart Flexware Assemblies for Chromatography is a fully-automated system designed to achieve optimum performance.
|
20120806 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Mar 15, 2012
This new single-use bioreactor allows biopharmaceutical manufacturers to implement robust, single-use technologies that bring their drugs to market faster, with less risk.
|
20120315 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Feb 12, 2012
With the Millistak+ µPod filter, users can easily connect multiple devices in parallel or series to rapidly screen combinations of media.
|
20120212 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Oct 22, 2013
The electronic Original Manufacturer Tracking (eOMT) saves users valuable time in research and enables compliance with regulatory requirements.
|
20131022 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Sep 18, 2012
Large-scale production of stem cells is necessary to enable their advancement into human clinical trials and to effectively deliver the quantities required.
|
20120918 |
Small Molecule Pharmaceuticals,Life Science Research,Biopharmaceutical Manufacturing |
|
Mar 21, 2012
This product, which utilizes Ventria’s ExpressTec biomanufacturing technology, will be exclusively marketed and distributed by MilliporeSigma to its customers on a global basis.
|
20120321 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Nov 13, 2012
User Group Meetings attract global biotechnology and biopharmaceutical industry professionals, including those in chromatography R&D, process development, production management and engineering.
|
20121113 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
|
Oct 18, 2012
The price adjustments are being driven by recent and anticipated cost increases, macroeconomic trends and inflation among other considerations.
|
20121018 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |
